Dachaigh › Cancer Pancreatic › Texas › San Antonio
Sgrùdaidhean clionaigeach Cancer Pancreatic ann an San Antonio, TX
Tha 31 sgrùdaidhean airson Cancer Pancreatic a’ lorg phàirtichean aig làraichean ann agus timcheall air San Antonio (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- Research Site, San Antonio
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A’ fastadhÌre 3
- Texas Oncology - San Antonio, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A’ fastadhÌre 3
- Investigative Site US080, San Antonio
- Investigative Site US063, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
A’ fastadhÌre 1
- NEXT, San Antonio
- START - San Antonio, San Antonio
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
A’ fastadhSgrùdadh amharc
- Children's Hospital of San Antonio, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
A’ fastadhÌre 2
- START- San Antonio, San Antonio
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
A’ fastadhÌre 1
- START San Antonio, San Antonio
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A’ fastadhÌre 3
- University of Texas Health Science Center at San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
A’ fastadhÌre 1
- New Experimental Therapeutics of San Antonio LLC, San Antonio
- START - South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
A’ fastadhÌre 1
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
A’ fastadhÌre 1
- START, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A’ fastadhÌre 1/2
- Next Oncology, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
A Study of MGC028 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
A’ fastadhÌre 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- START San Antonio, San Antonio
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A’ fastadhÌre 2
- Ohio State University-Telemedicine, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
A’ fastadhÌre 1/2
- START San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
A’ fastadhÌre 1/2
- Next Oncology, San Antonio, San Antonio
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #3, San Antonio
Sgrùdaidhean Cancer Pancreatic ann am bailtean eile
- Houston, TX61 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Boston, MA43 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- Los Angeles, CA35 sgrùdaidhean
- St. Louis, MO33 sgrùdaidhean
- Arlington, VA33 sgrùdaidhean
- Baltimore, MD31 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Tampa, FL26 sgrùdaidhean
- Durham, NC24 sgrùdaidhean
- San Diego, CA24 sgrùdaidhean
Sgrùdaidhean eile ann an San Antonio
- Aillse Sgamhain Neo-chealla-beag59 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Aillse colorectal46 sgrùdaidhean
- Ailse metastatach44 sgrùdaidhean
- Aillse (gach seòrsa)41 sgrùdaidhean
- Obesity40 sgrùdaidhean
- Diabaitis Seòrsa 237 sgrùdaidhean
- Ro-throm34 sgrùdaidhean
- Cancer Ovarian31 sgrùdaidhean
- Aillse Prostata28 sgrùdaidhean
- Ailse Endometrial27 sgrùdaidhean
- Ailseachadh nan Sgamhan26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.